Washington Post The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be able to order online starting next year.
Health experts say the convenience of the spray — FluMist — could lead to increased flu vaccination rates.
The maker of the vaccine, AstraZeneca, said it will supply the vaccine to a third-party online pharmacy where people can complete a screening assessment to determine if they are candidates. The pharmacy will then evaluate patients’ eligibility and decide if they are able to administer the vaccine.